Century Therapeutics, Inc. (IPSC)
NASDAQ · Healthcare
Century Therapeutics, Inc. Net Income 2022–2025
Century Therapeutics, Inc. annual/quarterly net income history and growth rate from 2022 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Century Therapeutics, Inc. net income for the quarter ending March 31, 2025 was 76.6 M, a 372.82% decrease year-over-year.
- Century Therapeutics, Inc. net income for the twelve months ending March 31, 2025 was -13.9 M, a 89.12% decrease year-over-year.
- Century Therapeutics, Inc. annual net income for 2025 was -9.6 M, a 92.43% decrease from 2024.
- Century Therapeutics, Inc. annual net income for 2024 was -126.6 M, a 7.40% decrease from 2023.
- Century Therapeutics, Inc. annual net income for 2023 was -136.7 M, a 4.38% increase from 2022.
- Century Therapeutics, Inc. annual net income for 2022 was -130.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Century Therapeutics, Inc. Net Income — FAQ
Century Therapeutics, Inc. (IPSC) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Century Therapeutics, Inc.'s net income?
Century Therapeutics, Inc. (IPSC) reported net income of -$10M for fiscal 2025.
Where can I see IPSC's net income history?
The chart and table above show Century Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.